Model-Informed Drug Discovery & Development
Services and software solutions across all modalities, indications, and pipeline stages
Early Research and Discovery
• Target ID and Validation
• Early Feasibility Assessment
• Lead ID and Screening
• Early Feasibility Assessment
• Lead ID and Screening
Learn more
Preclinical Studies
• Lead Optimization
• Clinical Candidate Selection
• Best-in-Class Design
• GLP/Tox
• Clinical Candidate Selection
• Best-in-Class Design
• GLP/Tox
Learn more
Clinical Studies
• IND Preparation
• First-in-Human Dose Prediction
• Study Design
• Clinical Pharmacology
• First-in-Human Dose Prediction
• Study Design
• Clinical Pharmacology
Learn more
Services
Our modeling approach identifies the ideal combination of mechanistic, semi-mechanistic, and statistical model components to most accurately answer your scientific questions.
Software
Applied BioMath Assess™ is an interactive, web-based application that helps assess the difficulties and risks in developing a therapeutic very early-on in a project.
Our Experience
>360
Collaborations
>160
Partner Companies
$6.9M
NIH and FDA Grant Funding
Many reasons to choose Applied BioMath
Companies We've Worked With
- AbbVie
- Alexion Pharmaceuticals
- Biogen
- Checkpoint Therapeutics
- Centivax
- Codiak Biosciences
- Compass Therapeutics
- CytomX Therapeutics
- Cullinan Oncology
- Flame Biosciences
- Gritstone Oncology
- Ironwood Pharmaceuticals
- Jounce Therapeutics
- KSQ Therapeutics
- Monte Rosa
- Northern Biologics
- Novartis
- Obsidian Therapeutics
- OncoMyx Therapeutics
- Pandion Therapeutics
- Pfizer
- Revitope
- Sanofi
- Shire
- Syntimmune
- Takeda
- Tusk Therapeutics
- Verseau Therapeutics
- Xencor
- Xilio Therapeutics
- Zymeworks
Resource Hub
Browse our publications, posters, case studies, webinars, software demos, press releases, events, and more.
